S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

GALT Galectin Therapeutics Inc

3.33

-0.17 (-4.86%)

Last Updated: 11:35:42

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

More Galectin Therapeutics Inc News Articles

Atacama Resources (PK)

NaturalShrimp (QB)

Mullen Automotive

Verb Technology

Moon Equity (PK)

BlackStar Enterprise (PK)

Globestar Therapeutics (PK)

International Star (PK)

MicroCloud Hologram

Global Developments (PK)

FuelCell Energy

NioCorp Developments

Movement Industries (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions